Milch, V.
21  Ergebnisse:
Personensuche X
?
1

Vaccine hesitancy in cancer patients: A rapid review:

Butow, P. ; Shaw, J. ; Bartley, N....
Patient Education and Counseling.  111 (2023)  - p. 107680 , 2023
 
?
2

Cancer Australia's Response to the COVID-19 Pandemic:

Milch, V. ; Hector, D. ; Turnbull, S....
Clinical Oncology.  33 (2021)  1 - p. e58-e60 , 2021
 
?
3

Interorganizational complexity—main challenges and opportun..:

, In: Safety and Reliability – Safe Societies in a Changing World,
Milch, V. ; Laumann, K. - p. 173-179 , 2018
 
?
4

Improving Outcomes Through Principles of Best Practice Mana..:

Daveson, B. ; Milch, V. ; Chynoweth, J....
Journal of Global Oncology.  4 (2018)  Supplement 2 - p. 243s-243s , 2018
 
?
6

P471 A Transcriptome-dependent Prognostic Model of Response..:

Johnson, T ; Reinisch, W ; Steere, B...
Journal of Crohn's and Colitis.  17 (2023)  Supplement_1 - p. i600-i600 , 2023
 
?
7

OP26 Efficacy and safety of mirikizumab as induction therap..:

D'Haens, G ; Kobayashi, T ; Morris, N...
Journal of Crohn's and Colitis.  16 (2022)  Supplement_1 - p. i028-i029 , 2022
 
?
8

OP28 Gene expression (GE) values in a phase 2 trial of miri..:

Steere, B ; GOTTLIEB, K ; Schmitz, J...
Journal of Crohn's and Colitis.  14 (2020)  Supplement_1 - p. S025-S026 , 2020
 
?
10

P130 - Gastrointestinal selectivity of vedolizumab (MLN0002..:

Parikh, A. ; Fedyk, E. ; Soler, D....
Journal of Crohn's and Colitis.  3 (2009)  1 - p. S62 , 2009
 
?
11

Gastrointestinal selectivity of vedolizumab (MLN0002), a hu..:

Parikh, A ; Fedyk, E ; Soler, D...
Inflammatory Bowel Diseases.  14 (2008)  - p. S18 , 2008
 
?
 
?
13

Stand der Kernfusionsforschung:

Hofmann, J. V. ; Milch, I. ; Wagner, F.
Vakuum in Forschung und Praxis.  5 (1993)  4 - p. 237-248 , 1993
 
1-15